Sunny Sanyal on growth strategy
From VAREX IMAGING (VREX) · · Sidoti Events
“Our play in India is all about radiographic to gain share back in radiographic and we expect that to be 100 million type of a product line. We talked about Photon counting by 2029 we expect the contribution from that to be in the range of 150 million and the third one cargo we expect that to be also a 100 million plus type of Revenue contributing segment over this strategic planning this 3 to 5 year horizon.”
On , Sunny Sanyal, President, Chief Executive Officer & Director at VAREX IMAGING CORP, spoke about growth strategy during VAREX IMAGING (VREX) on Sidoti Events.
About Sunny Sanyal
Sunny Sanyal, President and CEO of Varex Imaging, stated at a Sidoti conference in April 2025 that the impact of China’s anti-corruption campaign on the company’s sales is "largely behind us," though he noted lingering effects and said buying behavior among OEM customers in China has opened up with more positive sentiment. He said the company expects gradual improvement rather than a snapback. Sanyal also discussed the company’s position on tariffs, stating that the direct cost impact of tariffs is not significant and that the company has diversified its supply chain with suppliers in Europe, India, and self-sufficient operations in China. He said the selloff after the company’s earnings call was "not warranted." Sanyal highlighted several growth opportunities, including radiographic imaging from India, photon counting detectors expected to contribute $150 million by 2029, and cargo inspection as a new revenue segment. He said the company sells $20 to $25 million worth of photon counting detectors annually, with one global OEM on track for launch. Regarding the cargo inspection market, Sanyal said demand is being spurred by global security concerns and that the company’s linear accelerators can be used for material discrimination, a feature that may become more important with tariffs. He also stated that the destocking event among OEMs is "largely behind us," with an uptick in order intake rates in the fourth quarter and first quarter.